Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors [EARLY_Phase 1]

View source ↗

Summary

This document provides an update on an early-phase clinical trial evaluating the safety and efficacy of GT719 Universal Cell Injection in adults with relapsed/r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• GT719 Universal Cell Injection

Snippet

Sponsor: Grit Biotechnology | Conditions: Hematological Malignancy (Leukemia- Lymphoma) | EARLY_Phase 1 | Status: RECRUITING